Emerging Treatments for Cancer Using CyberKnife Technology
|Additional DVD options||Edition||Discs||
|New from||Used from|
(Jul 13, 2006)
CyberKnife is a highly refined type of stereotactic radiosurgery. It utilizes very accurately targeted doses of radiation to treat small tumors and other medical disorders. Noninvasive operations using CyberKnife technology have proven to be effective alternatives to conventional surgery or radiation. This program explores the emerging uses of CyberKnife for different types of cancer, as well as recent upgrades to CyberKnife technology such as Synchrony Motion Tracking for extracranial treatments of lung, pancreas and liver cases.
The original Cyberknife was developed at Stanford, where the first patient was treated in 1994. The prototype unit was used between 1994 and 2001. The Cyberknife was approved by the U.S. Food and Drug Administration (FDA) in 2001, and the first FDA-approved Cyberknife was installed at Stanford in October, 2001.
Iris Gibbs, MD, is Co-Director of the Cyberknife Radiosurgery Program at Stanford University Medical Center and Assistant Professor of Radiation Oncology at the Stanford University School of Medicine. Beyond CyberKnife, Linac radiosurgery, and extracranial radiosurgery, her areas of expertise include malignant brain tumors, pediatric brain tumors, acoustic neuroma, meningioma, intravascular brachytherapy, and IMRT.
|5 star (0%)|
|4 star (0%)|
|3 star (0%)|
|2 star (0%)|
|1 star (0%)|